These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 33060695)

  • 1. The structure of the antimicrobial human cathelicidin LL-37 shows oligomerization and channel formation in the presence of membrane mimics.
    Sancho-Vaello E; Gil-Carton D; François P; Bonetti EJ; Kreir M; Pothula KR; Kleinekathöfer U; Zeth K
    Sci Rep; 2020 Oct; 10(1):17356. PubMed ID: 33060695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural remodeling and oligomerization of human cathelicidin on membranes suggest fibril-like structures as active species.
    Sancho-Vaello E; François P; Bonetti EJ; Lilie H; Finger S; Gil-Ortiz F; Gil-Carton D; Zeth K
    Sci Rep; 2017 Nov; 7(1):15371. PubMed ID: 29133814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The C-Terminal VPRTES Tail of LL-37 Influences the Mode of Attachment to a Lipid Bilayer and Antimicrobial Activity.
    de Miguel Catalina A; Forbrig E; Kozuch J; Nehls C; Paulowski L; Gutsmann T; Hildebrandt P; Mroginski MA
    Biochemistry; 2019 May; 58(19):2447-2462. PubMed ID: 31016971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interactions of GF-17 derived from LL-37 antimicrobial peptide with bacterial membranes: a molecular dynamics simulation study.
    Aghazadeh H; Ganjali Koli M; Ranjbar R; Pooshang Bagheri K
    J Comput Aided Mol Des; 2020 Dec; 34(12):1261-1273. PubMed ID: 33009624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure and organization of the human antimicrobial peptide LL-37 in phospholipid membranes: relevance to the molecular basis for its non-cell-selective activity.
    Oren Z; Lerman JC; Gudmundsson GH; Agerberth B; Shai Y
    Biochem J; 1999 Aug; 341 ( Pt 3)(Pt 3):501-13. PubMed ID: 10417311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-quality 3D structures shine light on antibacterial, anti-biofilm and antiviral activities of human cathelicidin LL-37 and its fragments.
    Wang G; Mishra B; Epand RF; Epand RM
    Biochim Biophys Acta; 2014 Sep; 1838(9):2160-72. PubMed ID: 24463069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of LL-37 human cathelicidin peptide with a model microbial-like lipid membrane.
    Majewska M; Zamlynny V; Pieta IS; Nowakowski R; Pieta P
    Bioelectrochemistry; 2021 Oct; 141():107842. PubMed ID: 34049238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural Plasticity of LL-37 Indicates Elaborate Functional Adaptation Mechanisms to Bacterial Target Structures.
    Zeth K; Sancho-Vaello E
    Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34068993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primate cathelicidin orthologues display different structures and membrane interactions.
    Morgera F; Vaccari L; Antcheva N; Scaini D; Pacor S; Tossi A
    Biochem J; 2009 Feb; 417(3):727-35. PubMed ID: 18922132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular Dynamics Simulations of Human Antimicrobial Peptide LL-37 in Model POPC and POPG Lipid Bilayers.
    Zhao L; Cao Z; Bian Y; Hu G; Wang J; Zhou Y
    Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29652823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The activity and action mechanism of novel short selective LL-37-derived anticancer peptides against clinical isolates of Escherichia coli.
    Aghazadeh H; Memariani H; Ranjbar R; Pooshang Bagheri K
    Chem Biol Drug Des; 2019 Jan; 93(1):75-83. PubMed ID: 30120878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Spectroscopic Study of the Aggregation State of the Human Antimicrobial Peptide LL-37 in Bacterial versus Host Cell Model Membranes.
    Bonucci A; Caldaroni E; Balducci E; Pogni R
    Biochemistry; 2015 Nov; 54(45):6760-8. PubMed ID: 26502164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decoding the functional roles of cationic side chains of the major antimicrobial region of human cathelicidin LL-37.
    Wang G; Epand RF; Mishra B; Lushnikova T; Thomas VC; Bayles KW; Epand RM
    Antimicrob Agents Chemother; 2012 Feb; 56(2):845-56. PubMed ID: 22083479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular insights into the interactions of GF-17 with the gram-negative and gram-positive bacterial lipid bilayers.
    Jahangiri S; Jafari M; Arjomand M; Mehrnejad F
    J Cell Biochem; 2018 Nov; 119(11):9205-9216. PubMed ID: 30076752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cathelicidin Peptides Restrict Bacterial Growth via Membrane Perturbation and Induction of Reactive Oxygen Species.
    Rowe-Magnus DA; Kao AY; Prieto AC; Pu M; Kao C
    mBio; 2019 Sep; 10(5):. PubMed ID: 31506312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structures of human host defense cathelicidin LL-37 and its smallest antimicrobial peptide KR-12 in lipid micelles.
    Wang G
    J Biol Chem; 2008 Nov; 283(47):32637-43. PubMed ID: 18818205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimicrobial and protease inhibitory functions of the human cathelicidin (hCAP18/LL-37) prosequence.
    Zaiou M; Nizet V; Gallo RL
    J Invest Dermatol; 2003 May; 120(5):810-6. PubMed ID: 12713586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dermcidin-derived peptides show a different mode of action than the cathelicidin LL-37 against Staphylococcus aureus.
    Senyürek I; Paulmann M; Sinnberg T; Kalbacher H; Deeg M; Gutsmann T; Hermes M; Kohler T; Götz F; Wolz C; Peschel A; Schittek B
    Antimicrob Agents Chemother; 2009 Jun; 53(6):2499-509. PubMed ID: 19364862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acyl carrier protein is a bacterial cytoplasmic target of cationic antimicrobial peptide LL-37.
    Chung MC; Dean SN; van Hoek ML
    Biochem J; 2015 Sep; 470(2):243-53. PubMed ID: 26188040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unique features of human cathelicidin LL-37.
    Bandurska K; Berdowska A; Barczyńska-Felusiak R; Krupa P
    Biofactors; 2015; 41(5):289-300. PubMed ID: 26434733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.